BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Urgent Field Safety Notice for Remel Shigella Sonnei (Phase 1&2) Agglutinating Serum by Thermo Fisher Scientific Microbiology Basingstoke

Product group In-vitro diagnostics - microbiological products
Reference 12126/17

For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.

Urgent Field Safety Notice for Remel Shigella Sonnei (Phase 1&2) Agglutinating Serum by Thermo Fisher Scientific Microbiology Basingstoke , Download_VeroeffentlichtAm_EN PDF, 298KB, File does not meet accessibility standards